These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

100 related articles for article (PubMed ID: 15797176)

  • 41. A short version of the Hooper Visual Organization Test: development and validation.
    Merten T
    Clin Neuropsychol; 2002 May; 16(2):136-44. PubMed ID: 12221477
    [TBL] [Abstract][Full Text] [Related]  

  • 42. [NeuroCogFX--a computer-based neuropsychological assessment battery for the follow-up examination of neurological patients].
    Fliessbach K; Hoppe C; Schlegel U; Elger CE; Helmstaedter C
    Fortschr Neurol Psychiatr; 2006 Nov; 74(11):643-50. PubMed ID: 17103364
    [TBL] [Abstract][Full Text] [Related]  

  • 43. CAMcog as a screening tool for diagnosis of mild cognitive impairment and dementia in a Brazilian clinical sample of moderate to high education.
    Nunes PV; Diniz BS; Radanovic M; Abreu ID; Borelli DT; Yassuda MS; Forlenza OV
    Int J Geriatr Psychiatry; 2008 Nov; 23(11):1127-33. PubMed ID: 18464287
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Brief screening for mild cognitive impairment in elderly outpatient clinic: validation of the Korean version of the Montreal Cognitive Assessment.
    Lee JY; Dong Woo Lee ; Cho SJ; Na DL; Hong Jin Jeon ; Kim SK; You Ra Lee ; Youn JH; Kwon M; Lee JH; Maeng Je Cho
    J Geriatr Psychiatry Neurol; 2008 Jun; 21(2):104-10. PubMed ID: 18474719
    [TBL] [Abstract][Full Text] [Related]  

  • 45. An analysis of the Hooper Visual Organization Test with neurological patients.
    Merten T; Beal C
    Clin Neuropsychol; 1999 Nov; 13(4):521-9. PubMed ID: 10806465
    [TBL] [Abstract][Full Text] [Related]  

  • 46. The validity and reliability of the Turkish version of Alzheimer's Disease Assessment Scale-Cognitive Subscale (ADAS-Cog) in patients with mild and moderate Alzheimer's disease and normal subjects.
    Mavioglu H; Gedizlioglu M; Akyel S; Aslaner T; Eser E
    Int J Geriatr Psychiatry; 2006 Mar; 21(3):259-65. PubMed ID: 16477580
    [TBL] [Abstract][Full Text] [Related]  

  • 47. [Pilot study of the validity, reliability and normative data for PRO-NEURO scale in adult-elderly people without cognitive impairments].
    Adrián JA; Hermoso P; Buiza JJ; Rodríguez-Parra MJ; González M
    Neurologia; 2008 Jun; 23(5):275-87. PubMed ID: 18247189
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Rapid assessment of severe cognitive impairment in individuals with developmental disabilities.
    Walsh DM; Finwall J; Touchette PE; McGregor MR; Fernandez GE; Lott IT; Sandman CA
    J Intellect Disabil Res; 2007 Feb; 51(Pt 2):91-100. PubMed ID: 17217473
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Is cognitive reserve applicable to epilepsy? The effect of educational level on the cognitive decline after onset of epilepsy.
    Pai MC; Tsai JJ
    Epilepsia; 2005; 46 Suppl 1():7-10. PubMed ID: 15816971
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Seven minute screen performance in a normal elderly sample.
    Skjerve A; Nordhus IH; Engedal K; Pallesen S; Braekhus A; Nygaard HA
    Int J Geriatr Psychiatry; 2007 Aug; 22(8):764-9. PubMed ID: 17152118
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Paced visual serial addition test in multiple sclerosis.
    Nagels G; Geentjens L; Kos D; Vleugels L; D'hooghe MB; Van Asch P; Vuylsteke K; De Deyn PP
    Clin Neurol Neurosurg; 2005 Apr; 107(3):218-22. PubMed ID: 15823678
    [TBL] [Abstract][Full Text] [Related]  

  • 52. The Dysexecutive Questionnaire advanced: item and test score characteristics, 4-factor solution, and severity classification.
    Bodenburg S; Dopslaff N
    J Nerv Ment Dis; 2008 Jan; 196(1):75-8. PubMed ID: 18195646
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Clinical use of the Benton Visual Retention Test for children and adolescents with learning disabilities.
    Snow JH
    Arch Clin Neuropsychol; 1998 Oct; 13(7):629-36. PubMed ID: 14590624
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Mini-Mental Status Examination: mixed Rasch model item analysis derived two different cognitive dimensions of the MMSE.
    Schultz-Larsen K; Kreiner S; Lomholt RK
    J Clin Epidemiol; 2007 Mar; 60(3):268-79. PubMed ID: 17292021
    [TBL] [Abstract][Full Text] [Related]  

  • 55. A short neuropsychologic and cognitive evaluation of frontotemporal dementia.
    Valverde AH; Jimenez-Escrig A; Gobernado J; Barón M
    Clin Neurol Neurosurg; 2009 Apr; 111(3):251-5. PubMed ID: 19062159
    [TBL] [Abstract][Full Text] [Related]  

  • 56. [Assessment of chosen cognitive functions in children and adolescents with primary headaches].
    Zgorzalewicz M; Mojs E
    Przegl Lek; 2006; 63 Suppl 1():24-8. PubMed ID: 17471819
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Impairment versus deficiency in neuropsychological assessment: Implications for ecological validity.
    Silverberg ND; Millis SR
    J Int Neuropsychol Soc; 2009 Jan; 15(1):94-102. PubMed ID: 19128532
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Does self-weighting of items enhance the performance of an oral health-related quality of life questionnaire?
    Locker D; Berka E; Jokovic A; Tompson B
    Community Dent Oral Epidemiol; 2007 Feb; 35(1):35-43. PubMed ID: 17244136
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Implementing diagnostic criteria and estimating frequency of mild cognitive impairment in an urban community.
    Manly JJ; Bell-McGinty S; Tang MX; Schupf N; Stern Y; Mayeux R
    Arch Neurol; 2005 Nov; 62(11):1739-46. PubMed ID: 16286549
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Performance on the Benton Visual Retention Test in an educationally diverse elderly population.
    Seo EH; Lee DY; Choo IH; Youn JC; Kim KW; Jhoo JH; Suh KW; Paek YS; Jun YH; Woo JI
    J Gerontol B Psychol Sci Soc Sci; 2007 May; 62(3):P191-3. PubMed ID: 17507588
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.